Navigation Links
Australian Company Gets $10 million For Developing Skin Cancer Gel

The skin cancer gel developer Peplin has said that it would speed up the process of human testing of its fast-action cancer cream since it was able to get an amount of $10 //million from institutional investors for this purpose.

The company based in Queensland, Australia is developing the PEP005 compound as a treatment for actinic keratosis a pre-cancerous condition that leads to skin cancer. “You'll take a prescription to your pharmacist, you’ll get it filled with this neat little product, you’ll rub it on for a few days and you’ll see resolution of your new lesions,” said Peplin chief executive Michael Aldridge. He added that the gel would soon be available as a take-home prescription. Peplin said that it would begin the second phase of testing out the gel in clinical trials in United States and Australia in the New Year. “We think we have identified the right dose, the right concentration, well just focus in on exploring either side of that some shorter therapies, some longer therapies to see what sort of impact that has,” Mr Aldridge commented.

The company was able to raise $10 million after a trial involving 60 patients showed a 71 percent clearing of the sun spots that are usually a precursor to full blown skin cancer. "The major opportunity that we have is that our drug works following just a couple of days of treatment," Mr Aldridge said. "It’s very difficult to encourage people to put a cream on daily for weeks and months, they just don’t comply."


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Australian Health funds stand accused
4. Australian Court Finds Man Guilty of Spreading HIV/AIDS
5. Australian Scientists Develop Novel Drug To Combat Inflammatory Diseases
6. Sale Of Bird Flu Vaccine to US Planned: Australian Firm
7. Hepatitis C Could Infect 800,000 Australians By 2020
8. Obesity Cost More Than The Australian Health Budget
9. Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma
10. Fat Virus, Ad-36 Blamed For Obesity Epidemic In Australians
11. Its High Time the Australian Government Takes Steps against Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: a ... Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor of Word ... bachelor degree in religious education and a master degree in theology. , ““The Octagon ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... breast implants, a new scientific article suggests that autologous fat grafting—taking ... for achieving larger breasts naturally, without breast implants. , Cosmetic Surgeon and ...
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and ... with the bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of ... Association of Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks ...
(Date:1/24/2017)... ... January 23, 2017 , ... United Nations Foundation President and ... Mexico City Policy, also known as the Global Gag Rule, last enacted in ... foreign non-governmental organizations from receiving any U.S. foreign assistance for family planning if ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... with the acquisitions of two personal care service companies: Padre Home Health in ... effective January 1, 2017. , Well regarded in their respective markets, these two ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Direct-to-consumer digital marketing strategy drives 85% ... in consumable sales, quarter-over-quarter ... ), a leader in digital health and mobile health ... Monitoring System, an all-in-one diabetes meter, today announced continued ... smart diabetes management solution. In just ...
(Date:1/23/2017)... 2017 Research and Markets has announced the addition ... Product - Forecast to 2025" report to their offering. ... Report Highlights: ... to identify the investment opportunities Market forecasts till 2025, ... market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... NEW YORK , January 23, 2017 ... Biotech equities to see how they have fared at the close: ... BPMX), OvaScience Inc. (NASDAQ: OVAS ), and Regeneron Pharmaceuticals ... the NASDAQ, Biotechnology shares were relative laggards on Friday, January 20 ... can access our complimentary research reports on these stocks now at: ...
Breaking Medicine Technology: